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PRESIDENT GEORGE W. BUSH:
STEM CELL POLICY FROM
AUGUST 9, 2001 TO MARCH 8,
2009
On August 9, 2001, U.S. President
George W. Bush introduced a ban on fed-
eral funding for research on newly created
human embryonic stem (ES†) cell lines.
The policy was intended as a compromise
and specified that research on lines created
prior to that date would still be eligible for
funding. Seventy-one lines from 14 labora-
tories [1] across the globe met Bush’s eligi-
bility criteria, and scientists who wished to
investigate these lines could still receive
grants through the National Institutes of
Health (NIH). In practice, however, only 21
lines proved to be of any use to investiga-
tors [2].
CONSEQUENCES OF
THE BUSH POLICY
A slew of negative ramifications fol-
lowed for ES cell researchers. Now facing
restrictions on the type of research con-
ducted using federal funds, some scientists
were forced to create a dichotomous re-
search environment based on federal vs.
private funding of staff, equipment, and lab
space [3]. Collaboration and the sharing of
knowledge between scientists also was hin-
dered [4,5], andAmerican researchers who
previously spearheaded ES cell initiatives
were no longer able to offer much of a con-
tribution, stifling relationships with their
international counterparts [6].
Further aggravating the situation was
the fact that the 21 existing lines were not
genetically or ethnically diverse, meaning
specific disease processes (such as Parkin-
son’s) could no longer be studied in ES
cells. Similarly, any information gleaned
from the existing lines was limited to cer-
tain ethnicities, leaving uncertainty with re-
gard to cellular processes in minority
groups. In terms of therapeutic application,
all 21 lines were of decidedly poor utility
as they were cultured under inferior condi-
tions by today’s standards [7].
During this time, however, there were
several advances in the realm of stem cell
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tent stem (iPS) cells, whereby adult somatic
cells are induced to display properties con-
sistent with ES cells, were first generated in
mice by researchers in Japan [8]. Following
the discovery, theWhite House noted that by
“supporting alternative approaches, Presi-
dent Bush is encouraging scientific advance-
ment within ethical boundaries” [9].
Subsequent U.S. progress in iPS cell re-
search may have well enjoyed unique en-
couragement under Bush’s policies.
PRESIDENT BARACK OBAMA:
STEM CELL POLICY CHANGES
STARTING MARCH 9, 2009
On March 9, 2009, President Barack
Obama signed an Executive order revoking
the previous orders initiated under his pred-
ecessor and giving the NIH 120 days to re-
view the appropriate guidelines and issue
new criteria for stem cell research. The new
policyallowsfederallyfundedresearchersto
experiment on hundreds of viable ES cell
lines restricted under Bush. The reception in
thescientificcommunitywaslargelypositive
and echoed around the world, with claims of
“absolute excitement, enthusiasm, real hope
for the future” from some proponents [5].
Clearly, the issue was a popular one, with
oneWashington Post-ABCNews poll show-
ing thatalmost60 percent ofAmericans sup-
ported loosening restrictions on federal
funding for ES cell research [10]. Obama
was able to score major political points with
the public and the media, but challenges and
obstacles still remain for scientists.
Obama’s revocation of Bush’s policy
does not reverse the Dickey-Wicker amend-
ment, a law passed by Congress in 1996 that
prohibits federally funded investigators from
creating or causing harm to embryos.
Dickey-Wicker is a congressional issue, and
Obama has stated he intends it to remain that
way [11]. So although ES cell resources
have largely broadened for researchers, they
are still unable to create their own lines
using tax dollars — potentially problematic
for those who wish to study stem cells with
genetically specific or rare characteristics.
NIH GUIDELINES: EFFECTIVE
JULY 7, 2009
Scientists were concerned following the
April 17 release of the NIH draft regulations
that imposed stringent new ethical criteria in-
volving the informed consent of donors. The
pointofcontentionwasthatexistinglinescre-
ated under previous ethical guidelines would
not meet the technical specifications of the
new criteria — rendering them ineligible for
federal funding [12]. Such a scenario would
haveresultedinfewerEScelllineoptionsthan
undertheBushadministration.However,after
receivingapproximately49,000commentson
the draft, the NIH released their finalized
guidelinesonJuly6,alsosummarizingandad-
dressing the major draft concerns. The final
guidelinesspecifiedthatthenewethicalcrite-
riaonlywouldbeappliedtolinesderivedonor
afterJuly7,2009,andresearchonpre-existing
lines that do not comply with the new regula-
tions would “undergo review by a Working
Group of the Advisory Committee to the Di-
rector(ACD)”[13]todeterminefundingeligi-
bility.TheNIHalsoannouncedthecreationof
a registry to document all ES cell lines ap-
proved for eligibility.
As in the draft, the final regulations only
allow funding for research involving unused
embryosfromfertilityclinics,excludingthose
embryoscreatedspecificallyforresearchpur-
poses or derived from other sources.
CONCLUSION
Stemcellresearchisahotlydebatedissue
onCapitolHillandlikelywillremainsointhe
coming years. However, federalism and the
presenceofwealthydonorshaveallowedsev-
eral states and major academic institutions to
bypass the NIH entirely and function inde-
pendently[14].Nevertheless,asObamamade
clear on March 9, “(m)edical miracles do not
happen simply by accident. They result from
painstakingandcostlyresearch…andfroma
governmentwillingtosupportthatwork”[15].
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